Help Community - Describe Your Efalizumab Side Effect

Have You experienced Efalizumab side effects?
Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results


Would you rather lose weight or save money?
Is It Really FDA Approved?


      Advertisements

Health Expert

Health Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question about Efalizumab? Ask a Health Expert!

Vaccine Safety

View Community-reported Efalizumab side effects

Add Your Side Effect to the Community Database

Help Community - Describe Your Efalizumab Side Effect

Have You dealt with a Efalizumab side effect? Share your experience

Health Expert

A Health Expert wants to answer your Health question.

Please provide details below.


Efalizumab Side Effects summary

Total Efalizumab reports: 87.
Efalizumab FDA safety alerts: 2005 .
Reported deaths: 20    Reported hospitalizations: 57.
Take Efalizumab Side Effects Survey, Discuss Efalizumab with others
Efalizumab Side Effects: arthralgia, condition aggravated, asthenia, back pain, psoriasis, varices oesophageal, splenomegaly, hepatic neoplasm malignant, dermatitis exfoliative, anorexia, aspartate aminotransferase increased,
More About Efalizumab.
If you have questions about Efalizumab, you can ask a Health Expert or Ask Patient Community about Efalizumab.

Efalizumab Side Effects reported to FDA

Showing 1-40 of 87 Next >

Efalizumab Side Effects Report #5486009-8
Physician from UNITED STATES reported EFALIZUMAB problem on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. EFALIZUMAB dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5490795-0
EFALIZUMAB problem was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. EFALIZUMAB dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5501195-9
Physician from UNITED STATES reported EFALIZUMAB problem on Oct 17, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. EFALIZUMAB dosage: 1 MG, UNK. Patient recovered.



Efalizumab Side Effects Report #5501970-0
EFALIZUMAB problem was reported by a Physician from UNITED STATES on Oct 16, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: pneumonia fungal. EFALIZUMAB dosage: 1 MG, 1/WEEK. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized. Patient recovered.




Efalizumab Side Effects Report #5453160-8
Physician from UNITED STATES reported EFALIZUMAB problem on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. EFALIZUMAB dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5468549-0
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on Sept 21, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: endocarditis. EFALIZUMAB dosage: 1.3 ML, 1/WEEK. Patient was hospitalized and became disabled. Patient recovered.



Efalizumab Side Effects Report #5472076-4
Physician from UNITED STATES reported EFALIZUMAB problem on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. EFALIZUMAB dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5413591-9
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on Aug 02, 2007. Male patient, 62 years of age, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. EFALIZUMAB dosage: unknown. During the same period patient was treated with FOSINOPRIL, PRAVASTATIN. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5376479-8
Physician from SWITZERLAND reported EFALIZUMAB problem on June 18, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, lupus-like syndrome, vitamin b1 deficiency, vitamin b12 deficiency. EFALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.




Efalizumab Side Effects Report #5380641-8
EFALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Male patient, weighting 197.8 lb, was diagnosed with psoriasis, back pain and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: mental status changes. EFALIZUMAB dosage: 0.08 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID, KETOCONAZOLE, NPH INSULIN, REGULAR INSULIN, NORCO. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5383037-8
Physician from SWITZERLAND reported EFALIZUMAB problem on June 27, 2007. Female patient, 49 years of age, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-cell lymphoma, chronic lymphocytic leukaemia. EFALIZUMAB dosage: unknown. Patient recovered.



Efalizumab Side Effects Report #5386881-6
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on July 05, 2007. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: endometrial cancer. EFALIZUMAB dosage: 1 MG, 1/WEEK. Patient recovered.



Efalizumab Side Effects Report #5399213-4
Physician from SWITZERLAND reported EFALIZUMAB problem on July 20, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, lupus-like syndrome, vitamin b1 deficiency, vitamin b12 deficiency. EFALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5376479-8
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, lupus-like syndrome, vitamin b1 deficiency, vitamin b12 deficiency. EFALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.




Efalizumab Side Effects Report #5380641-8
Consumer or non-health professional from UNITED STATES reported EFALIZUMAB problem on June 25, 2007. Male patient, weighting 197.8 lb, was diagnosed with psoriasis, back pain and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: mental status changes. EFALIZUMAB dosage: 0.08 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID, KETOCONAZOLE, NPH INSULIN, REGULAR INSULIN, NORCO. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5383037-8
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on June 27, 2007. Female patient, 49 years of age, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-cell lymphoma, chronic lymphocytic leukaemia. EFALIZUMAB dosage: unknown. Patient recovered.



Efalizumab Side Effects Report #5386881-6
Physician from SWITZERLAND reported EFALIZUMAB problem on July 05, 2007. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: endometrial cancer. EFALIZUMAB dosage: 1 MG, 1/WEEK. Patient recovered.



Efalizumab Side Effects Report #5399213-4
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on July 20, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, lupus-like syndrome, vitamin b1 deficiency, vitamin b12 deficiency. EFALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5756065-8
Physician from SWITZERLAND reported EFALIZUMAB problem on May 29, 2008. Female patient was diagnosed with psoriasis, venous stasis, contraception, insomnia and was treated with EFALIZUMAB. EFALIZUMAB dosage: 0.9 ML, 1/WEEK. During the same period patient was treated with DIOSMIN, ETONOGESTREL, BROMAZEPAM. Patient died on 01/03/2008.




Efalizumab Side Effects Report #5756066-X
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on May 29, 2008. Female patient was diagnosed with psoriasis, contraception and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative. EFALIZUMAB dosage: 1 ML, 1/WEEK. During the same period patient was treated with NORGESTREL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5771790-0
Physician from SWITZERLAND reported EFALIZUMAB problem on June 09, 2008. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: appendicitis, arthralgia, pneumonia. EFALIZUMAB dosage: 0.9 ML, 1/WEEK. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5781141-3
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on June 16, 2008. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: folliculitis. EFALIZUMAB dosage: 100 MG, 1/WEEK. Patient recovered.



Efalizumab Side Effects Report #5781149-8
Physician from SWITZERLAND reported EFALIZUMAB problem on June 13, 2008. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased, papilloedema, visual disturbance. EFALIZUMAB dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5788252-7
EFALIZUMAB problem was reported by a Physician from CANADA on June 20, 2008. Male patient was diagnosed with psoriasis, psoriatic arthropathy, medical diet, hypertension and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypertension, psoriatic arthropathy, pulmonary embolism. EFALIZUMAB dosage: 0.7 MG/KG, SINGLE. During the same period patient was treated with SULFASALAZINE, DIPROSALIC, GLUCOSAMINE, CAPTOPRIL, FISH OIL. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5728871-7
Physician from UNITED STATES reported EFALIZUMAB problem on Apr 28, 2008. Female patient, weighting 185.0 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. EFALIZUMAB dosage: 1 MG, 1/WEEK. Patient was hospitalized and became disabled. Patient recovered.



Efalizumab Side Effects Report #5735500-5
EFALIZUMAB problem was reported by a Health Professional from SWITZERLAND on May 06, 2008. Female patient, 44 years of age, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: fibrous histiocytoma. EFALIZUMAB dosage: 1 MG/KG, 1/WEEK. Patient recovered.



Efalizumab Side Effects Report #5743107-9
Physician from SWITZERLAND reported EFALIZUMAB problem on May 15, 2008. Female patient was diagnosed with psoriasis, venous stasis, contraception, insomnia and was treated with EFALIZUMAB. EFALIZUMAB dosage: 0.9 ML, 1/WEEK. During the same period patient was treated with DIOSMIN, ETONOGESTREL, BROMAZEPAM. Patient died on 01/03/2008.



Efalizumab Side Effects Report #5748199-9
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on May 20, 2008. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: appendicitis, arthralgia, pneumonia. EFALIZUMAB dosage: 0.9 ML, 1/WEEK. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5693088-1
Physician from UNITED STATES reported EFALIZUMAB problem on Apr 02, 2008. Male patient, 58 years of age, weighting 224.0 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: back pain, haemorrhage, musculoskeletal chest pain, nodule, pyrexia, skin lesion. EFALIZUMAB dosage: 1MG/KG/WEEK 1ONCE WEEKLY SQ. During the same period patient was treated with ALLOPURINOL, INDOMETHACIN. Patient recovered.



Efalizumab Side Effects Report #5701279-6
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on Mar 26, 2008. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hepatic enzyme increased, leukocytosis, meningitis aseptic, septic shock, systemic inflammatory response syndrome. EFALIZUMAB dosage: 100 MG/ML, 1/WEEK. During the same period patient was treated with DICLOFENAC, CARBAMAZEPINE. Patient was hospitalized. Patient died on 11/17/2006.



Efalizumab Side Effects Report #5711987-9
Physician from SWITZERLAND reported EFALIZUMAB problem on Apr 17, 2008. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: colon cancer. EFALIZUMAB dosage: 0.4 ML, 1/WEEK. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5711988-0
EFALIZUMAB problem was reported by a Physician from UNITED STATES on Apr 09, 2008. Male patient was diagnosed with graft versus host disease and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebral aspergillosis, myocarditis, pneumonia. EFALIZUMAB dosage: 50 MG, 1/WEEK. During the same period patient was treated with AMBIEN, CALCIUM, CELLCEPT, CLARITIN, CLONAZEPAM, CYMBALTA, DURAGESIC. Patient died on 10/16/2007.



Efalizumab Side Effects Report #5722249-8
Physician from SWITZERLAND reported EFALIZUMAB problem on Apr 14, 2008. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hepatic enzyme increased, leukocytosis, meningitis aseptic, septic shock, systemic inflammatory response syndrome. EFALIZUMAB dosage: 100 MG/ML, 1/WEEK. During the same period patient was treated with DICLOFENAC, CARBAMAZEPINE. Patient was hospitalized. Patient died on 11/17/2006.



Efalizumab Side Effects Report #5357846-5
EFALIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 08, 2007. Male patient, 35 years of age, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: arthritis, hepatitis, psoriasis. EFALIZUMAB dosage: unknown. Patient recovered.



Efalizumab Side Effects Report #5372565-7
Consumer or non-health professional from UNITED STATES reported EFALIZUMAB problem on June 18, 2007. Male patient, weighting 197.8 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: aphasia. EFALIZUMAB dosage: 0.08 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID, KETOCONAZOLE. Patient recovered.



Efalizumab Side Effects Report #5324041-5
EFALIZUMAB problem was reported by a Physician from UNITED STATES on May 04, 2007. Female patient, weighting 205.4 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis. EFALIZUMAB dosage: 125 MG, 1/WEEK. During the same period patient was treated with NORVASC, DETROL LA, LASIX, ACCUPRIL, HYDROCHLOROTHIAZIDE, ACTOS. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5285424-5
Health Professional from SWITZERLAND reported EFALIZUMAB problem on Mar 22, 2007. Male patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. EFALIZUMAB dosage: 0.186 ML, 1/WEEK. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, VALSARTAN AND HYDROCHLOROTHIAZIDE, SIMVASTATIN, INSULIN. Patient died on 02/20/2007.



Efalizumab Side Effects Report #5295376-X
EFALIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Male patient, 78 years of age, weighting 156.5 lb, was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, splenomegaly, varices oesophageal. EFALIZUMAB dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with METHOTREXATE, ADALIMUMAB, LISINOPRIL, DOXORUBICIN. Patient recovered.



Efalizumab Side Effects Report #5302016-X
Physician from SWITZERLAND reported EFALIZUMAB problem on Apr 18, 2007. Female patient was diagnosed with psoriasis, platelet aggregation and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction. EFALIZUMAB dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.



Efalizumab Side Effects Report #5308832-2
EFALIZUMAB problem was reported by a Physician from SWITZERLAND on Apr 23, 2007. Female patient was diagnosed with psoriasis, hypertension and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal strangulated hernia, duodenal ulcer, ovarian enlargement, small intestinal obstruction, spinal fusion surgery, wound dehiscence. EFALIZUMAB dosage: 1 MG/KG, 1/WEEK. During the same period patient was treated with DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.



Showing 1-40 of 87 Next >


PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about prescription drug side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding Efalizumab safety information and found answers to Your Questions about Efalizumab side effects

, Efalizumab was diagnosed with psoriasis, irritable bowel syndrome and Efalizumab was diagnosed with psoriasis, irritable bowel syndrome and